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Summary
The nematode parasites that cause human lymphatic filariasis survive for long periods in their
vascular habitats despite continualexposure to host cells. Sinceprostanoids formed from arachidonic
acid can modulate interactions among platelets, leukocytes, and endothelial cells, we examined
whether intravascular nematode parasites can elaborate prostanoids. Microfilariae of Brugia malayi
utilize exogenous and endogenous arachidonic acid to generate and release two predominant
prostanoids, prostacyclin and prostaglandin E2. Filarial metabolism of host fatty acids to form
these vasodilatory, antiaggregatory, and immunomodulatory eicosanoids provides a means by
which these helminthic parasites may influence host immune and other cellular responses.
L
mphatic filariasis, a mosquito-borne parasitic disease that
affects >100 millionpeople worldwide, is caused by the
intravascular nematodes Wuchereria bancrofti, Brugia malayi,
and B. timori. As with other helminthic parasites that live
for long periods in host organs (1), little is known about
how filariae overcome host cellular responses to survive and
causechronicdisease. Adult filarial wormsinhabit lymphatic
vessels, and their larval offspring, microfilariae, live in the
bloodstream. Microfilariae are motile multicellular worms
that repeatedly encounter host leukocytes, platelets, and vas-
cular endothelial cells. Despite their size (ti220 Am long by
-10 Am in diameter), microfilariae are not usually irrevers-
ibly trapped within small blood vessels, and neither platelets
nor granulocytes adhere to microfilariae in vivo. In infected
personswith detectable microfilaremia, lymphocytesrespond
poorly to parasite antigens, and levels of parasite-specific an-
tibody are low (2). Since microfilariae represent the parasite
stageingested by mosquito vectors, survival of microfilariae
is important not only forthe individual infected human host,
but also for the transmission of filarial infection to other
humans.
Filarial parasites cannot producepolyunsaturatedfattyacids
de novo (3), but essential fattyacidsareavailableto microfilariae
in humanplasma. Microfilariaeavidly incorporate exogenous
arachidonic acid into parasite phospholipids (4, 5), and can
also form arachidonic acid from exogenous linoleic acid (6).
Prostanoids, generated from arachidonic acid via the cycloox-
ygenase pathwayin mammalian cells, exert a spectrum of po-
tent paracrine actions that can modulate interactions among
platelets, leukocytes, and endothelial cells (7). We therefore
examined whether intravascular filarial parasites can trans-
form arachidonic acid into prostanoids.
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Materials and Methods
Isolation ofMic%filariae.
￿
Microfilariae were obtained by saline
peritoneal lavage ofS malayi-infectedjirds and separatedfromjird
peritoneal cellsby passage over aSephadex G25column equilibrated
with RPMI 1640 (8) to yield >99% viable (motile) microfilariae.
After purification, jird peritoneal cells were routinelyundetectable
in hemacytometer counts of 103 microfilariae, so <103 potentially
contaminatingjird cells, if any, were present per 106 microfilariae.
Biosynthesis and Release ofMicro,filarial Prostanoids.
￿
106 microfi-
lariae were incubated with 50 nM 3H-arachidonic acid (201 Ci/
mmol;Amersham Corp., Arlington Heights, IL) in 1 ml ofRPMI
1640,pH 7.4, at 37°C for30 min, afterwhichmediaandparasites
were separated by centrifugation. Lipids in incubation media and
ultrasonically disruptedparasites were extractedwith 2volof acid-
ified ether (5), andresolved forprostanoids by reverse-phaseHPLC
using a 4.6-mm x 10-cm Microsorb C18 column (Rainin Instru-
ment Co. Inc., Woburn, MA) and an on-line radioactive flow detec-
tor(Flo-1 (3; Radiomatic Instruments &Chemical Co. Inc., Tampa,
FL). The column was eluted with an isocratic acetonitrile/water
(27:73 [vol/vol] 2 ml/min) mobile phase (9). Radiolabeled materials
ofinterest were collected in 2-ml fractions and rechromatographed
with a second HPLC solvent system consisting ofalinear gradient
(1 ml/min) from water/acetonitrile/TFA (60:40:0.0008 [vol/vol/
vol]) to methanol/acetonitrile/TFA (60:40:0.002 [vol/vol/vol]) over
40 min (9).
For TLCresolution ofradiolabeled lipidextracts, silica gelTLC
plates (LK5D; Whatman Inc., Clifton, NJ) were developed with
theorganic phase of ethyl acetate/isoctane/glacial acetic acid/H20
(110:50:20:100 [vol/vol/vol]) (10) and scanned with a TLC radia-
tion detector (model RS; Radiomatic Instruments &Chemical Co.
Inc.). Migrations of microfilarial 3H-labeled prostanoids were com-
pared with cochromatographed lipid standards.
To assess microfilarial prostanoid biosynthesis in the absenceof
exogenous arachidonic acid, microfilariae (106) were incubated in
1 ml of RPMI 1640, pH 7.4, supplemented with 10 mM Hepes,
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5% C02 for 24 h, after which microfilarial viability (uptake of
acridine orange-ethidium bromide [111) was >98%. Prostanoids
were measured by RIA usingprostanoid class-specific antisera (Ad-
vanced Magnetics, Cambridge, MA). Released prostanoids were
assayed directly in unextracted incubation media, while retained
products in parasites were extracted (5) and resolved by TLC to
remove crossreacting materials before RIA (10). In some experi-
ments, microfilariae were incubated with pharmacologic inhibitors
of arachidonic acid metabolism, and 6-keto-PGF1, in the incuba-
tion media was quantitated by RIA. Theseinhibitors included in-
domethacin (100 pM), compound BW755c (100 uM), and5,8,11,14-
eicosatetraynoic acid (ETYA; 20 /jM).
Results and Discussion
To investigate parasite metabolismofexogenous arachidonic
acid, B. malayi microfilariae were incubated with IH-arachi-
donic acid for 30 min. Lipids extracted from incubation media
and from parasites were resolved by HPLC. Incubationmedia
contained two major 311-labeled products that coeluted with
authentic prostaglandin E2 (PGE2) and 6-keto-PGFta, the
stable hydrolysis product of prostacyclin (Fig. 1 A). These
311-labeled products, when individually collected and ana-
lyzed with a second HPLC system, again coeluted with
PGE2 and 6-keto-PGF1a (Fig. 1 B). TLC of lipid extracts
further confirmed the formation of 311-labeled PGE2 and
6-keto-PGF1,, with -0.8% of total 311-arachidonic acid
converted to each of these radiolabeled products (data not
shown). These radiolabeled products were not formed by heat-
killed microfilariae, and only small amounts were formed by
microfilariae incubated at 4'C (data not shown) .
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Table I.
￿
Biosynthesis and Release of Microfilarial Prostanoids
from Endogenous Arachidonate
Prostanoid production
Values shown are means ± SEM (n = 3-6). Immunoreactive
material was not detected in control media incubated without para-
sites. Media from jird peritoneal cells (8 x 107) after 24-h incuba-
tion contained 520 pg TXB2, only 102 pg PGE2, and no
6-keto-PGF1..
The utilization of endogenous stores of arachidonate for
the formation and release ofprostanoids by parasites was evalu-
ated by RIA, after incubating microfilariae in serum-free media
for 24 h. The predominant prostanoids formed by microfi-
lariae from endogenous arachidonic acid, as from exogenous
311-arachidonic acid, were prostacyclin and PGE2 (Table 1).
A small amount of PGD2, but no PGF2« or thromboxane
B2 (the stable hydrolysis product of TXA2), was detected in
the incubation media. Only minimal amounts of prostanoids
Figure 1.
￿
311-labeled prostanoids
generated by B malayi microfilariae
from exogenous 311-arachidonic acid.
(A) Parasite-derived [3111-labeled lipids
extracted from incubation media (solid
line) and microfilariae (dotted line),
resolved by HPLC as described in
Materials and Methods. (B) Analysis of
311-labeled products collected from
peaks labeled I and II in (A), and indi
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system, as described in Materials and
Methods. Retention times of 6-keto-
PGFt, (6kPGFt~), thromboxane B2
(TXB2), PGF2~, PGE2, PGD2, and ara-
chidonic acid (AA) standards are indi-
cated (arrows). In control experiments,
isolated jird peritoneal cells (107), in-
cubated with 311-arachidonic acid, as for
microfilariae, produced no detectable
311-labeled prostanoids.
Prostanoid Released Retained
pg/106 microfilariae
6kPGFt. 1,971 ± 511 97 ± 64
PGE2 801 ± 131 68 ± 45
PGD2 192 ± 56 76 ± 45
PGF2a 0 29 ± 15
TXB2 0 0remained within microfilariae, as also found with microfilariae
incubated with 3H-arachidonic acid (Fig. 1 A), indicating
that newly formed parasite eicosanoids were released and not
stored. Further evidence of parasite prostanoid release has been
obtained using fluorescence immunocytochemistry, in which
PGEZ was visualized around the surface of microfilariae with
specific anti-PGEZ antiserum (Liu, LX, J .E. Buhlman, and
P.F. Weller, unpublished results).
Several pharmacologic inhibitors of mammalian arachidonic
acid metabolism were evaluated to determine their impact
on microfilarial prostanoid biosynthesis: indomethacin,
BW755c (a pyrazoline antioxidant), and ETYA (the poly-
acetylenic analogue of arachidonic acid) (7). Microfilarial
prostacyclin productionwas inhibited 95% by indomethacin
(100 AM), 97% by BW755c (100 AM), and 92% by ETYA
(20 AM) (means of three experiments), in comparison with
incubations without inhibitors. None of the inhibitors cross-
reacted with 6-keto-PGFi« antisera, and none were lethal to
microfilariae (viability >83% for all experiments) .
Microfilariae of B. malayi, therefore, utilized both exoge-
nous and endogenous arachidonic acid to generate cyclooxy-
genase-derived eicosanoids. Microfilariae elaborated prosta-
noids in an apparently constitutive manner, not dependent
on exogenous stimulants. Furthermore, prostanoids formed
by microfilariae were released into the medium surrounding
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